"Continuous Improvement:" Defining Your Purification Process & Product Specifications

In this Bioprocess Online Live panel discussion, John Stubenrauch, Ph.D., Chief Operations Officer at Nutcracker Therapeutics, Hari Pujar, Ph.D., Chief Operating Officer at Tessera, and Anna Rose Welch, Chief Editor at Cell & Gene Collaborative discuss go-to best practices, suggestions, and experiences for prioritizing and streamlining technical operations endeavors to prepare for the clinic and, eventually, the commercial market. Here, Stubenrauch and Pujar talk about where the greatest sources of variability are in our downstream processes and how companies should be approaching the question of “how pure is pure enough?"

View the full presentation here.